Simplex Trading, LLC Fulgent Genetics, Inc. Transaction History

Simplex Trading, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$19.09 - $22.57 $46,694 - $55,206	-2,446 Reduced 57.61%	1,800 $35,000
Q1 2024 Apr 25, 2024	BUY	$21.55 - $29.29 $38,337 - $52,106	1,779 Added 72.11%	4,246 $92,000
Q4 2023 Feb 02, 2024	BUY	$23.64 - $30.27 $58,319 - $74,676	2,467 New	2,467 $71,000
Q2 2023 Aug 04, 2023	BUY	$28.52 - $40.7 $243,304 - $347,211	8,531 Added 346.09%	10,996 $407,000
Q1 2023 Apr 27, 2023	BUY	$29.39 - $36.27 $72,446 - $89,405	2,465 New	2,465 $76,000
Q3 2022 Nov 04, 2022	BUY	$37.92 - $63.74 $202,341 - $340,116	5,336 New	5,336 $203,000
Q1 2022 May 02, 2022	SELL	$49.85 - $96.11 $92,970 - $179,245	-1,865 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$77.3 - $105.0 $22,417 - $30,450	290 Added 18.41%	1,865 $187,000
Q3 2021 Oct 28, 2021	SELL	$74.87 - $110.87 $14,974 - $22,174	-200 Reduced 11.27%	1,575 $137,000
Q2 2021 Aug 12, 2021	BUY	$66.8 - $100.45 $118,570 - $178,298	1,775 New	1,775 $163,000
Q1 2021 Apr 26, 2021	SELL	$59.3 - $183.85 $1.24 Million - $3.85 Million	-20,949 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$31.01 - $52.1 $626,339 - $1.05 Million	20,198 Added 2689.48%	20,949 $1.09 Million
Q3 2020 Oct 14, 2020	BUY	$15.89 - $50.51 $11,933 - $37,933	751 New	751 $30,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.